Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     In Vitro Diagnostics     Immunoassay    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Fluorescence Immunoassays (FIA) Market Research Report

  • Report Code: FL 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

Fluorescence immunoassays (FIA) accounted for a share of about 11.2% in the overall immunoassays market in 2012. FIA gives the same sensitivity as radioimmunoassay (RIA) and enzyme immunoassays (EIA), but at a lower cost, since the fluorescent dyes are available at lower prices as compared to enzymes and radioisotopes.

 

The increasing automation of immunoassays, increasing demand for safer and stable reagents, and development of novel markers such as laser-induced fluorescence probes, and fluorescence-activated cell sorters are the recent trends in the global FIA market. Rapid processing time, improved sensitivity than colorimetric measurements, low cost, and flexibility in development into homogenous or heterogeneous assays are the major reasons behind the growth of this segment.

 

The report ‘Global Fluorescence immunoassays (FIA) Market forecast for 2018’ analyzes the market by three segments, namely instruments, reagents, and applications.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The key market players under this segment are Abbott Laboratories (Architect ci8200), Bio-Rad Laboratories, Inc (BioPlex 2200), Danaher Corporation (Beckman Coulter-UniCelDxl800), and Siemens Medical Solutions Diagnostics, Inc. (Siemens Immulite 2000).

 

Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

 

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

 

Opportunity Analysis

  • Unmet needs, revenue pockets, and potential areas for expansion
  • Comprehensive review of key component providers, assay providers, sole service providers, and complete solution providers

 

Current and Emerging Products

  • Analysis of current and emerging fluorescence immunoassays (FIA) and immunodiagnostic tests
  • Review of current instrumentation technologies

 

Pricing Trends

  • Pricing trend of new high value immunoassay tests

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • End-user adoption rate analysis of the products (segment wise and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

Alternative Products: Impact analysis

 

MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).



1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology

 

2 Executive Summary
 

3 Market Overview
 

4 By Applications
4.1 Cancer
4.2 Endocrine disorders
4.3 Cardiovascular Disorders
4.4 Infectious disease
4.5 Auto-immune Diseases
4.6 Blood Disorders
4.7 Bone and Mineral Disorders
4.8 Toxicology Screening

 

5 By Endusers
5.1 Hospitals
5.2 Medical & Diagnostic Laboratories
5.3 Pharmaceuticals
5.4 Contract Research Organization (CRO)
6 By Types
6.1 Medium Throughput
6.2 Low Throughput
6.3 High Throughput
 

7 By Geographies
7.1 Americas
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of World
 

8 By Companies
8.1 Siemens AG Healthcare
8.2 Johnson & Johnson
8.3 BioMérieux
8.4 Abbott Laboratories

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Fluorescence Immunoassays (FIA) Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Europe Fluorescence Immunoassays (FIA) Europe Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “European Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
Asia Fluorescence Immunoassays (FIA) Asia Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “Asian Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.  
Upcoming
North America Fluorescence Immunoassays (FIA) North America Fluorescence Immunoassays (FIA)
Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “North American Fluorescence immunoassays (FIA) Market forecast for 2018“ analyzes the market by three segments such as instruments, reagents and applications.  
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539